
Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Retatrutide Biologic Battle: The Story Gets Bigger

GLP-1 Showdown: Inside The High Stakes War over Patients

Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know

Compound GLP-1 Poll STUNS THE INTERNET!
Free AI-powered recaps of On The Pen GLP-1 News and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.